Search
Now showing items 1-10 of 128
Toxocarosis seroprevalence in blood donorsSeroprevalencia de toxocarosis en donantes de sangre
(Archivos de Medicina Veterinaria, 1998)
Establishment of the first platelet-donor registry in Argentina
(Società Italiana di Medicina Trasfusionale e Immunoematologia, 2020-07)
Background: Platelet transfusions are necessary to prevent and treat haemorrhages in thrombocytopenic patients or those with severe platelet dysfunction. In Latin American countries, including Argentina, blood supplies ...
Decreasing trends in HTLV-1/2 but stable HIV-1 infection among replacement donors in Argentina
(Wiley-liss, Div John Wiley & Sons Inc, 2010-05)
In Argentina, current procedures to ensure safety of the blood supply for transfusion include reviewing the records of blood donors with particular attention to the serologic detection of specific blood borne infections. ...
Gender-neutral donor deferral policies: experience in Argentina implementing individual risk-assessment policies
(Wiley Blackwell Publishing, Inc, 2020-10)
Background: In Argentina, with the aim of moving to a safe supportive and inclusive National Blood System, in September 2015 the Ministry of Health stipulated that eligibility criteria for blood donation should only take ...
Vein to vein: exploring blood supply chains in Canada
(FGV EAESP, 2018)
Human parvovirus B19 frequency among blood donors after an epidemic outbreak: relevance of the epidemiological scenario for transfusion medicine
(Elsevier, 2020-05)
A retrospective, cross-sectional study was conducted to determine the frequency of human parvovirus B19 (B19V) infected individuals, viral loads and immunity among blood donors from Argentina, in a post-epidemic outbreak ...
First hepatitis B virus full-length genomic study among blood donors from Argentina: unexpected mutations in the circulating subgenotypes’ proteins
(Springer, 2015-04)
Hepatitis B virus (HBV) is a worldwide public health concern. The circulation of strains carrying mutations in the viral proteins implies both clinical and therapeutics challenges. HBV complete genomes (HBV-CGs) were ...